#JALANKITA: Pemantauan Penyakit Komorbid Penyulit Covid-19 Berbasis Android pada Lansia di Masa Pandemi di Kota Balikpapan

#JALANKITA: Monitoring of Covid-19 Comorbidities on Android Base for the Elderly in the Pandemic Period in the Balikpapan City

  • Joshua Gaza Dirgantara Tandirogang Program Studi Kedokteran, Fakultas Kedokteran, Universitas Mulawarman
  • Swandari Paramita Laboratorium Ilmu Kesehatan Masyarakat, Fakultas Kedokteran, Universitas Mulawarman
  • Yadi Yadi Laboratorium Mikrobiologi, Fakultas Kedokteran, Universitas Mulawarman
Keywords: covid-19, Digital Technology, Health Application

Abstract

Elderly or commonly referred to as seniors is the age category that has the highest mortality rate due to Covid-19 infection, this is due to not only because of the age factor but also due to comorbid diseases that many elderly suffer from. At present, the use of smartphones has reached the elderly category and has been widely used for daily needs. Seeing this phenomenon, this study has the aim of using an Android-based application in observing and monitoring to see the comorbidities of Covid-19 in the elderly. This study used 112 samples in the city of Balikpapan and aged over 50 years old which was conducted for 3 days in August 2020. This research is a descriptive study and the sampling is purposive sampling. The results in this study showed that the most respondents were 50-59 years of age, the most sexes were women and the most comorbid diseases suffered were high blood pressure or hypertension

References

[1] T. Singhal, “Review on COVID19 disease so far,” Indian J. Pediatr., vol. 87, no. April, pp. 281–286, 2020, doi: 10.1007/s12098-020-03263-6.
[2] World Health Organization, “Corona Virus Disease-19 Global Situation,” World Health Organization. https://covid19.who.int/ (accessed Sep. 22, 2020).
[3] CDC, “Older Adults At greater risk of requiring hospitalization or dying if diagnosed with COVID-19,” 2020. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/older-adults.html (accessed Sep. 23, 2020).
[4] SATUAN TUGAS PENANGANAN COVID-19, “PETA PERSEBARAN,” 2020. https://covid19.go.id/peta-sebaran (accessed Sep. 23, 2020).
[5] Amber L. Mueller, Maeve S.McNamara, and David A. Sinclair, “Why does COVID-19 disproportionately affect older people?,” Aging (Albany. NY)., vol. 12, no. 10, pp. 9959–9981, 2020.
[6] A. Sanyaolu et al., “Comorbidity and its Impact on Patients with COVID-19,” SN Compr. Clin. Med., vol. 2, no. 8, pp. 1069–1076, 2020, doi: 10.1007/s42399-020-00363-4.
[7] Kementrian Komunikasi dan informatika, “Survey Penggunaan Teknologi Informasi dan Komunikasi,” Jakarta, 2017.
[8] Kementrian Kesehatan, Pedoman Pencegahan dan Pengendalian Corona Virus Disease-19. 2020.
[9] C. M. Petrilli et al., “Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study.,” BMJ, vol. 369, p. m1966, May 2020, doi: 10.1136/bmj.m1966.
[10] W.-J. Guan et al., “Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.,” Eur. Respir. J., vol. 55, no. 5, May 2020, doi: 10.1183/13993003.00547-2020.
[11] M. Nikpouraghdam et al., “Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study.,” J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol., vol. 127, p. 104378, Jun. 2020, doi: 10.1016/j.jcv.2020.104378.
[12] H. Mori et al., “Comparison of COVID-19 disease between young and elderly patients: Hidden viral shedding of COVID-19.,” J. Infect. Chemother. Off. J. Japan Soc. Chemother., vol. 27, no. 1, pp. 70–75, Jan. 2021, doi: 10.1016/j.jiac.2020.09.003.
[13] S. Huang et al., “COVID-19 patients with hypertension have more severe disease: a multicenter retrospective observational study.,” Hypertens. Res., vol. 43, no. 8, pp. 824–831, Aug. 2020, doi: 10.1038/s41440-020-0485-2.
[14] F. Pamungkas, T. Hariyanto, and E. Woro U, “Identifikasi Ketidaklengkapan Dokumen Rekam Medis Rawat Inap di RSUD Ngudi Waluyo Wlingi,” J. Kedokt. Brawijaya, vol. 28, no. 2, pp. 124–128, 2015, doi: 10.21776/ub.jkb.2015.028.02.2.
Published
2021-10-31
How to Cite
Tandirogang, J. G. D., Paramita, S., & Yadi, Y. (2021). #JALANKITA: Pemantauan Penyakit Komorbid Penyulit Covid-19 Berbasis Android pada Lansia di Masa Pandemi di Kota Balikpapan. Jurnal Sains Dan Kesehatan, 3(5), 639-644. https://doi.org/10.25026/jsk.v3i5.480